4.7 Article

Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode Litomosoides sigmodontis

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects

Adebayo J. Molehin et al.

Summary: Schistosomiasis, a neglected tropical parasitic disease caused by human blood flukes, lacks an available vaccine despite being ranked as one of the top 10 urgently needed vaccines by Science. This review highlights the current progress of schistosomiasis vaccines under clinical development and emphasizes the need for revolutionary and effective vaccine pipeline utilizing cutting-edge technologies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, Research & Experimental

RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection

Samira Marx et al.

Summary: The therapeutic use of the RIG-I activator 3pRNA improves survival and reduces disease severity in mice infected with SARS-CoV-2. Mice treated with 3pRNA show lower viral load, reduced lung inflammation, and develop a specific neutralizing antibody response against SARS-CoV-2.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Multidisciplinary Sciences

Spherical nucleic acids as an infectious disease vaccine platform

Michelle H. Teplensky et al.

Summary: This study explores how the presentation of vaccine components in spherical nucleic acids (SNAs) can induce and maximize antiviral response. The SNA vaccine, encapsulating the receptor-binding domain (RBD) subunit and decorated with Toll-like receptor 9 agonist oligonucleotides, shows promising results in inducing immune responses in human cells and mice, outperforming traditional vaccines.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Immunology

Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis

Lisa Luu et al.

Summary: This study evaluated the protective effects of co-administering leading O. volvulus-derived recombinant vaccine candidates with subsequent natural exposure to a closely related cattle parasite. The results showed that vaccinated calves had a significantly lower rate of infection compared to unvaccinated control animals. Furthermore, the levels of specific antibodies were negatively correlated with adult female worm burdens. The findings suggest that vaccine formulations for human onchocerciasis should aim to elicit similarly balanced immune responses.

VACCINES (2022)

Review Immunology

Eosinophils in filarial infections: Inducers of protection or pathology?

Alexandra Ehrens et al.

Summary: This review summarizes the importance of eosinophil effector functions in controlling filarial infections and their impact on filarial pathology. Eosinophils play a crucial role in the immune response against filariae by modulating the function of other leukocytes and directly attacking the parasites. They are both beneficial in controlling the infection and can contribute to disease pathology in certain conditions.

FRONTIERS IN IMMUNOLOGY (2022)

Review Parasitology

Human filariasis-contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model

Frederic Risch et al.

Summary: Filariae are parasitic nematodes that are transmitted by vectors such as mosquitoes, and are endemic in tropical and subtropical regions worldwide. Efforts to control and eliminate filarial diseases have been ongoing since the 1970s, focusing on mass drug administration and vector control strategies. The goal is to reduce transmission and ultimately eliminate filarial diseases as a public health concern.

PARASITOLOGY RESEARCH (2021)

Review Pharmacology & Pharmacy

Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines

Saed Abbasi et al.

Summary: In recent years, the rise of minimalist approaches has led to the development of multifunctional immunoadjuvants, which have become an important trend in nucleic acid subunit vaccines. These adjuvants possess functions such as encoding antigens, encapsulating nucleic acids, and controlling pharmacokinetics, activating the immune system and inducing specific immune responses.

PHARMACEUTICS (2021)

Review Immunology

Development of a recombinant vaccine against human onchocerciasis

David Abraham et al.

Summary: The development of a prophylactic vaccine for onchocerciasis is crucial for achieving the goal of eliminating the disease by 2030. Various animal models have shown promising results in inducing protective immunity, laying the foundation for future clinical trials to evaluate the vaccine's effectiveness in humans.

EXPERT REVIEW OF VACCINES (2021)

Review Cell Biology

A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications

Furong Qin et al.

Summary: Nucleic acid vaccines show promising prospects in clinical applications due to their high efficiency and low cost compared to traditional vaccines, but their development is hindered by low immunogenicity and instability. Research efforts are focused on enhancing their immunogenicity and stability to support further progress in clinical applications.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Parasitology

Advances in Vaccine Development for Human Lymphatic Filariasis

Ramaswamy Kalyanasundaram et al.

TRENDS IN PARASITOLOGY (2020)

Review Parasitology

Onchocerca volvulus: The Road from Basic Biology to a Vaccine

Sara Lustigman et al.

TRENDS IN PARASITOLOGY (2018)

Review Immunology

Immunomodulation by Helminths: Intracellular Pathways and Extracellular Vesicles

Amin Zakeri et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Immunology

Discriminating self from non-self in nucleic acid sensing

Martin Schlee et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Infectious Diseases

Release of Small RNA-containing Exosome-like Vesicles from the Human Filarial Parasite Brugia malayi

Mostafa Zamanian et al.

PLOS NEGLECTED TROPICAL DISEASES (2015)

Review Immunology

Translating nucleic acid-sensing pathways into therapies

Tobias Junt et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Review Immunology

Type I interferons in infectious disease

Finlay McNab et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Review Immunology

Immunology of lymphatic filariasis

S. Babu et al.

PARASITE IMMUNOLOGY (2014)

Article Multidisciplinary Sciences

Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity

Amy H. Buck et al.

NATURE COMMUNICATIONS (2014)

Article Immunology

Multivalent fusion protein vaccine for lymphatic filariasis

Gajalakshmi Dakshinamoorthy et al.

VACCINE (2013)

Article Infectious Diseases

Combined TLR7/8 and TLR9 Ligands Potentiate the Activity of a Schistosoma japonicum DNA Vaccine

Xuefeng Wang et al.

PLOS NEGLECTED TROPICAL DISEASES (2013)

Review Immunology

Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination

Christophe J. Desmet et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Review Infectious Diseases

Filariasis in Africa-treatment challenges and prospects

A. Hoerauf et al.

CLINICAL MICROBIOLOGY AND INFECTION (2011)

Review Immunology

Diversity and dialogue in immunity to helminths

Judith E. Allen et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Article Infectious Diseases

Evaluation of Wuchereria bancrofti GST as a Vaccine Candidate for Lymphatic Filariasis

Anandharaman Veerapathran et al.

PLOS NEGLECTED TROPICAL DISEASES (2009)

Article Multidisciplinary Sciences

5′-triphosphate RNA is the ligand for RIG-I

Veit Hornung et al.

SCIENCE (2006)

Article Multidisciplinary Sciences

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

L Alexopoulou et al.

NATURE (2001)

Review Immunology

Type 1 type 2 immunity in infectious diseases

B Spellberg et al.

CLINICAL INFECTIOUS DISEASES (2001)